Vaccines: Chasing the dream

Nature

Volumn 475, Issue 7355 SUPPL., 2011, Pages

  Schnabel, Jim ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE VACCINE; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN ANTIBODY; AMYLOID BETA PROTEIN[1-42]; BAPINEUZUMAB; IMMUNOGLOBULIN; TAU PROTEIN;

BRAIN; DISEASE TREATMENT; IMMUNE SYSTEM; MEMORY; NERVOUS SYSTEM DISORDER; PROTEIN; SYMPTOM; VACCINATION; VACCINE;

AGING; ALZHEIMER DISEASE; ANTIBODY RESPONSE; ARTICLE; CEREBROSPINAL FLUID; CREUTZFELDT JAKOB DISEASE; DRUG MEGADOSE; ENCEPHALITIS; HUMAN; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PRESCRIPTION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN TARGETING; QUALITY OF LIFE; VACCINATION;

ALZHEIMER DISEASE; ALZHEIMER VACCINES; AMYLOID; AMYLOID BETA-PEPTIDES; ANIMALS; ANTIBODIES, MONOCLONAL; CLINICAL TRIALS AS TOPIC; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MICE; TAU PROTEINS;

EID: 79960359900     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/475S18a     Document Type: Article

References (6)

1. Gilman, S. et al. Neurology 64, 1553-1562 (2005).
2. Hughes, R. A. C. et al. Clin. Exp. Immunol. 158 (Suppl 1), 34-42 (2009).
3. Salloway, S. et al. Neurology 73, 2061-2070 (2009).
4. Rinne, J. O. et al. Lancet Neurol. 9, 363-372 (2010).
5. Jin, M. et al. Proc. Natl Acad. Sci. USA 108, 5819-5824 (2011).
6. Goñi, F. et al. PLoS One 5, e13391 (2010).